Référentiel des médicaments
Rebamipide
Rebamipide is a medicine in the class gastrointestinal tract. It is used for gastritis.
- Classe médicamenteuse: Gastrointestinal Tract
- Indications: gastritis
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Gastrointestinal Tract
- Formes courantes
- comprimé, sachet
- Dosages courants
- 100 mg, 0.5 mg
- Noms commerciaux
- 7
- Pays et marchés
- 1
Indications
Mécanisme d'action
Prostaglandin Increasing Effect: Rebamipide increased the endogenous prostaglandin E2 (PGE2) content in the gastric mucosa. Cytoprotective Effect: Rebamipide exhibited a gastric cytoprotective effect by inhibiting mucosal damage induced by ethanol, strong acid and strong base.
Posologie adulte habituelle (résumé de la notice)
1 tab orally 3 times daily, (in the morning, in the evening and before bedtime).
Grossesse et allaitement
- Grossesse
- Unknown No FDA or EU label; Japanese label: give only if benefit outweighs risk (passes to the fetus in rats). Human data are lacking. For gastritis or ulcers in pregnancy, antacids or better-studied drugs (e.g. famotidine) are preferred.
- Allaitement
- Unknown Not known if it passes into human milk; it passes into rat milk; no LactMed record. Japanese label: decide whether to continue breastfeeding, weighing benefits. Prefer famotidine or omeprazole, which have milk data.
Effets indésirables signalés
- Dry mouth
- Constipation
- Dizziness
Contre-indications
- History of hypersensitivity to rebamipide or to any other ingredient of the product.
Précautions particulières
- Shock and anaphylaxis have been reported; stop treatment and give appropriate treatment if signs of hypersensitivity occur.
- Leukopenia and thrombocytopenia have been reported; monitor and discontinue if abnormalities occur.
- Hepatic dysfunction, including raised AST, ALT, gamma-GTP and alkaline phosphatase, and jaundice have been reported; monitor and discontinue if abnormalities occur.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Rebamipide : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Patient counselling points
- Food interactions
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres médicaments de cette classe
Questions fréquentes
What is Rebamipide used for?
Rebamipide is a medicine in the class gastrointestinal tract. It is used for Gastritis, Peptic ulcer.
What side effects have been reported with Rebamipide?
Dry mouth, Constipation, Dizziness.
Can Rebamipide be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No FDA or EU label; Japanese label: give only if benefit outweighs risk (passes to the fetus in rats). Human data are lacking. For gastritis or ulcers in pregnancy, antacids or better-studied drugs (e.g. famotidine) are preferred. Breastfeeding: Unknown. Not known if it passes into human milk; it passes into rat milk; no LactMed record. Japanese label: decide whether to continue breastfeeding, weighing benefits. Prefer famotidine or omeprazole, which have milk data.
What does Rebamipide interact with?
MediHelp does not list a checked interaction for Rebamipide yet. Always tell your pharmacist about every medicine you take.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
